-
Revenue
$-6.73M
Net Income
-
Gross Margin
-
Op. Margin
$-10.64M
Free Cash Flow
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Total Revenue | $83.41K | $33.26K | - | - | - | - |
| Revenue Growth % (YoY) | nan% | nan% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $68.04K | $26.73K | - | - | - | - |
| Gross Profit | $15.37K | $6.52K | - | - | - | - |
| Gross Margin % | 18.4% | 19.6% | nan% | nan% | nan% | nan% |
| Operating Expenses | $1.59M | $1.48M | $2.06M | $1.77M | $1.82M | $1.68M |
| Research & Development | $345.99K | $480.30K | $576.26K | $590.86K | $566.58K | $513.70K |
| Operating Income | $-1.57M | $-1.47M | $-2.06M | $-1.77M | $-1.82M | $-1.68M |
| Operating Margin % | -1881.8% | -4419.1% | nan% | nan% | nan% | nan% |
| Interest Expense | $5.01K | $3.46K | $1.01K | $2.01K | $16.15K | $11.17K |
| Other Income/Expense | $18.07K | $20.94K | $39.07K | $54.02K | $56.48K | $70.32K |
| Net Income | $-1.55M | $-1.45M | $-2.02M | $-1.71M | $-1.76M | $-1.61M |
| Net Margin % | -1860.2% | -4356.2% | nan% | nan% | nan% | nan% |
| Basic EPS | -0.15 | -0.15 | -0.21 | -0.18 | -0.22 | -0.20 |
| Diluted EPS | -0.15 | -0.15 | -0.21 | -0.18 | -0.22 | -0.20 |
| Basic Shares Outstanding | 10.4M | 9.7M | 9.7M | 365K | 8.1M | 8.1M |
| Diluted Shares Outstanding | 10.4M | 9.7M | 9.7M | 365K | 8.1M | 8.1M |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.99M | $2.47M | $3.80M | $5.44M | $4.24M | $5.61M |
| Accounts Receivable | $58.34K | - | - | - | - | - |
| Other Current Assets | $487.02K | - | - | - | - | - |
| Total Current Assets | $2.54M | $2.70M | $4.08M | $5.55M | $4.60M | $6.07M |
| Property Plant & Equipment | $2.96K | $3.39K | $3.82K | $4.25K | $4.68K | $5.11K |
| Total Assets | $2.70M | $2.87M | $4.09M | $5.55M | $4.60M | $6.08M |
| Accounts Payable | $168.21K | $181.79K | $210.53K | $435.93K | $91.37K | $82.02K |
| Short-term Debt | $55.61K | $110.29K | $164.07K | - | $172.00K | $341.04K |
| Accrued Liabilities | $534.88K | $363.92K | $464.79K | $152.16K | $515.66K | $268.44K |
| Total Current Liabilities | $758.70K | $681.08K | $839.40K | $588.09K | $779.04K | $691.49K |
| Total Liabilities | $758.70K | $681.08K | $839.40K | $588.09K | $779.04K | $691.49K |
| Common Stock | $104.00 | $96.00 | $94.00 | $91.00 | $79.00 | $79.00 |
| Retained Earnings | $-21.81M | $-20.26M | $-18.81M | $-16.79M | $-15.05M | $-13.29M |
| Total Stockholders Equity | $1.94M | $2.19M | $3.25M | $4.96M | $3.82M | $5.39M |
| Total Liabilities & Equity | $2.70M | $2.87M | $4.09M | $5.55M | $4.60M | $6.08M |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $-1.55M | $-3.47M | $-2.02M | $-1.71M | $-1.76M | $-1.61M |
| Stock-based Compensation | $856.42K | $478.19K | $300.29K | $214.28K | $729.37K | $527.80K |
| Change in Receivables | $58.34K | - | - | - | - | - |
| Change in Payables | $-267.72K | $-254.14K | $-225.40K | $344.56K | $-12.28K | $-21.64K |
| Operating Cash Flow | $-4.34M | $-3.23M | $-1.80M | $-1.27M | $-4.34M | $-3.13M |
| Stock Issued | $941.39K | $262.46K | - | - | - | - |
| Financing Cash Flow | $997.00K | $372.75K | $164.07K | $2.47M | $5.95M | $6.12M |
| Net Change in Cash | $-3.34M | $-2.86M | $-1.63M | $1.20M | $1.61M | $2.99M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $83.41K | - | $116.67K | - |
| Cost of Revenue | $68.04K | - | $94.78K | - |
| Gross Profit | $15.37K | - | $21.89K | - |
| Operating Expenses | $1.59M | - | $5.12M | - |
| Research & Development | $345.99K | - | $1.40M | - |
| Operating Income | $-1.57M | - | $-5.10M | - |
| Interest Expense | $1.54K | - | $5.01K | - |
| Other Income/Expense | $18.07K | - | $78.08K | - |
| Net Income | $-1.55M | $-1.61M | $-5.02M | - |
| Basic EPS | -0.15 | - | -0.51 | - |
| Diluted EPS | -0.15 | - | -0.51 | - |
| Basic Shares Outstanding | $10.38M | - | $9.93M | - |
| Diluted Shares Outstanding | $10.38M | - | $9.93M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $1.99M | $5.44M |
| Accounts Receivable | $58.34K | - |
| Other Current Assets | $487.02K | $111.60K |
| Total Current Assets | $2.54M | $5.55M |
| Property Plant & Equipment | $2.96K | $4.25K |
| Total Assets | $2.70M | $5.55M |
| Accounts Payable | $168.21K | $435.93K |
| Short-term Debt | $55.61K | - |
| Accrued Liabilities | $534.88K | $152.16K |
| Total Current Liabilities | $758.70K | $588.09K |
| Total Liabilities | $758.70K | $588.09K |
| Common Stock | $104.00 | $91.00 |
| Retained Earnings | $-21.81M | $-16.79M |
| Total Stockholders Equity | $1.94M | $4.96M |
| Total Liabilities & Equity | $2.70M | $5.55M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-1.55M | $-1.61M | $-5.02M | - |
| Stock-based Compensation | - | - | $856.42K | - |
| Change in Receivables | - | - | $58.34K | - |
| Change in Payables | - | - | $-267.72K | - |
| Operating Cash Flow | - | - | $-4.34M | - |
| Investing Cash Flow | - | - | - | - |
| Stock Issued | - | - | $941.39K | - |
| Financing Cash Flow | - | - | $997.00K | - |
| Net Change in Cash | - | - | $-3.34M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.